+ Follow SUIS Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 582518
[Title] => Hungry gourmand
[Summary] => MILLIE: “Je suis gourmand.
[DatePublished] => 2010-06-10 00:00:00
[ColumnID] => 134170
[Focus] => 0
[AuthorID] => 1805395
[AuthorName] => Millie and Karla Reyes
[SectionName] => Food and Leisure
[SectionUrl] => food-and-leisure
[URL] =>
)
[1] => Array
(
[ArticleID] => 267647
[Title] => Evidence mounts for gut worm therapy
[Summary] => Two sets of findings presented at the 2004 Digestive Disease Week meeting lend strength to the belief that helminthic therapy may be a highly effective treatment for inflammatory bowel disease (IBD) in a double-blind, randomized, placebo-controlled study that included 54 patients with ulcerative colitis (UC), approximately 50 percent of the patients responded to Trichurisuis ova therapy.
In addition, in an open-label study of 29 patients with refractory Crohns disease (CD), 79.3 percent of the subjects responded to treatment, and 72.4 percent achieved clinical remission.
[DatePublished] => 2005-01-02 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
SUIS
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 582518
[Title] => Hungry gourmand
[Summary] => MILLIE: “Je suis gourmand.
[DatePublished] => 2010-06-10 00:00:00
[ColumnID] => 134170
[Focus] => 0
[AuthorID] => 1805395
[AuthorName] => Millie and Karla Reyes
[SectionName] => Food and Leisure
[SectionUrl] => food-and-leisure
[URL] =>
)
[1] => Array
(
[ArticleID] => 267647
[Title] => Evidence mounts for gut worm therapy
[Summary] => Two sets of findings presented at the 2004 Digestive Disease Week meeting lend strength to the belief that helminthic therapy may be a highly effective treatment for inflammatory bowel disease (IBD) in a double-blind, randomized, placebo-controlled study that included 54 patients with ulcerative colitis (UC), approximately 50 percent of the patients responded to Trichurisuis ova therapy.
In addition, in an open-label study of 29 patients with refractory Crohns disease (CD), 79.3 percent of the subjects responded to treatment, and 72.4 percent achieved clinical remission.
[DatePublished] => 2005-01-02 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
)
)
abtest